Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial NCT07445295 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07445295
- Sponsor
- Chipscreen Biosciences, Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-31
- Primary completion
- 2028-06-30
- Enrollment
- 558
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.